You are using an outdated browser. Please upgrade your browser to improve your experience.

icotinib

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Icotinib is a new epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that developed and used in China for the treatment of patients with non-small cell lung cancer (NSCLC).
Synonyms & Links
Guide to Pharmacology: 7641
DrugCentral: 5209
LyCHI:  5P9F71NB22TL


Target Activities